|Prepared by ChinaScope Financial | Source: Company Disclosure
- Sihuan Pharmaceutical Holdings Group Ltd. (00460: HKG) announced on March 25 that company net profit attributable to common shareholders for 2012 increased 9.8 percent year-on-year (YoY) to CNY 904 million. Basic earnings per share for the reporting period stood at CNY 0.1748. The company declared a final dividend of CNY 0.058 per share for 2012.
- Company revenue for 2012 increased 35.7 percent YoY to CNY 3.04 billion, thanks to the increase in sales value of its cardio-cerebral vascular drugs. The gross profit for the reporting period increased 33.5 percent YoY to CNY 2.29 billion, and the gross profit margin decreased slightly from 76.5 percent in 2011 to 75.2 percent in 2012.
- Sihuan Pharmaceutical Holdings Group Ltd. is principally engaged in the manufacture and sale of pharmaceutical products in mainland China.
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.